European Lung Cancer Conference 2016

Oncology Meeting Resources

13 Apr - 16 Apr, Geneva, Switzerland

ELCC 2016

The European Lung Cancer Conference is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, all working towards a shared goal: to advance science, disseminate education and improve the practice of lung cancer specialists worldwide. 

ELCC 2016 abstracts, webcasts and presentations are now available here for ESMO members to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Useful Links

Presenter Presentation title Session title
Solange Peters Welcome to the Conference Opening and Welcome
Rolf A. Stahel Introduction to ESMO Opening and Welcome
Fred Hirsch Introduction to IASLC Opening and Welcome
Suresh Senan Curative treatment of early-stage NSCLC: Lessons learned from comparative effectiveness research and future directions Heine H. Hansen Award Lecture
Andrew Nicholson Staging update on SCLC SCLC: Advances and state of the art
John Poirier Genetics and genetic targets in SCLC SCLC: Advances and state of the art
Martin Edelman Translational studies in SCLC SCLC: Advances and state of the art
Kaoru Kubota Advances in systemic treatment of SCLC excluding immunotherapy SCLC: Advances and state of the art
Paul Baas Non-surgical treatment options for mesothelioma Mesothelioma: An update
David Planchard T790M inhibitor as first line therapy: Promises and pitfalls Targeting T790M
Shun Lu Oligometastatic NSCLC with driver mutations: Guidelines and practical application Oligometastatic NSCLC
Egbert Smit Oligometastatic NSCLC without driver mutations: New developments, including immunotherapy Oligometastatic NSCLC
Yi-Long Wu Surgery in oligometastatic disease Oligometastatic NSCLC
Tony S.K. Mok A new era of T790M inhibition Targeting T790M
Suresh Ramalingam Mechanism of resistance to T790M inhibitors Targeting T790M